The Cost-Effectiveness of Neoadjuvant Chemoradiation is Superior to a Surgery-First Approach in the Treatment of Pancreatic Head Adenocarcinoma

Cost-effectiveness of modern radiotherapy techniques in locally advanced pancreatic cancer

(2011) James D. Murphy et al.   CANCER

Bending the Cost Curve in Cancer Care

(2011) Thomas J. Smith et al.   NEW ENGLAND JOURNAL OF MEDICINE

Adjuvant therapy and survival after resection of pancreatic adenocarcinoma

(2010) Skye C. Mayo et al.   CANCER

Cost-Utility Estimation of Surgical Treatment of Pancreatic Carcinoma Aimed at Cure

(2010) David Ljungman et al.   WORLD JOURNAL OF SURGERY

Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages

(2010) Sonja Gillen et al.   PLOS MEDICINE

The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United States

(2008) Karl Y. Bilimoria et al.   ANNALS OF SURGICAL ONCOLOGY

Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head

(2008) Gauri R. Varadhachary et al.   JOURNAL OF CLINICAL ONCOLOGY

Analysis of Fluorouracil-Based Adjuvant Chemotherapy and Radiation After Pancreaticoduodenectomy for Ductal Adenocarcinoma of the Pancreas: Results of a Large, Prospectively Collected Database at the Johns Hopkins Hospital

(2008) Joseph M. Herman et al.   JOURNAL OF CLINICAL ONCOLOGY

Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head

(2008) Douglas B. Evans et al.   JOURNAL OF CLINICAL ONCOLOGY

Neoadjuvant Therapy for Pancreatic Cancer

(2008) Andrew M. Lowy   JOURNAL OF GASTROINTESTINAL SURGERY

Borderline Resectable Pancreatic Cancer: The Importance of This Emerging Stage of Disease

(2008) Matthew H.G. Katz et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS